Skip to main content
SpringerLink
Log in

Glycogen storage disease I and hepatocellular tumours

  • Treatment and complications in GSD type Ib
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

From 50 published cases of hepatocellular adenoma (HCA) in glycogen storage disease, type I (GSD I) some characteristic features may be deduced: 1. The male: female ratio was 2∶1. This sharply contrasts to HCA of other origin which shows a strong female preponderance. 2. The histology of adenomas largely corresponded to other adenomas, except for the appearance of Mallory bodies, accompanied by neutrophilic inflammation and a peculiar lamellar fibrosis. This observation is of particular interest because Mallory bodies have so far not been described in adenomas but are a well established feature in hepatocellular carcinoma of any aetiology. 3. Adenomas had a tendency to regress after continuous nocturnal intragastric feeding, although not all cases responded favourably. 4. Ten cases of hepatocellular carcinoma (HCC) are recorded in GSD I in literature, whereby in half of them transition from HCA into HCC seems likely. 5. The similarity in clinical presentation and evolution with oestrogen-induced tumours is striking. Pathogenesis of adenoma formation in GSD I is not understood. Experimental evidence and the clinical observation of regression after correction of the metabolic imbalance suggest three possible candidate mechanisms: (1) a glucagon/insulin imbalance; (2) cellular glycogen overload; and (3) proto-oncogene activation. Evidence in favour of these three mechanisms from experimental studies and observations in humans are briefly reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

GSDI:

glycogen storage disease, type I

HCA:

hepatocellular adenoma

HCC:

hepatocellular carcinoma

FNH:

focal nodular hyperplasia

IGF:

(nocturnal) intragastric feeding

References

  1. Bannasch P, Müller HA (1964) Lichtmikroskopische Untersuchung über die Wirkung von N-Nitrosomorpholin auf die Leber von Ratte und Maus. Arzneimittelforsch 14:805–814

    PubMed  Google Scholar 

  2. Bannasch P, Mayer D, Hacker HJ (1980) Hepatocellular glycogenosis and hepatocarcinogenesis. Biochim Biophys Acta 605:217–245

    PubMed  Google Scholar 

  3. Bannasch P, Hacker HJ, Klimek F, Mayer D (1983) Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis. Adv Enzyme Regul 22:97–121

    Google Scholar 

  4. Bannasch P, Enzmann H, Hacker HJ, et al (1989) Comparative pathobiology of hepatic pre-neoplasia. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 55–76

    Google Scholar 

  5. Bianchi L (1983) Liver biopsy interpretation in hepatitis. Part I: presentation of critical morphologic features used in diagnosis (glossary). Path Res Pract 178:2–19

    PubMed  Google Scholar 

  6. Biondetti PR, Fiore D, Muzzio PC (1980) Computed tomography of the liver in von Gierke's disease. J Comput Assist Tomogr 4:685–686

    PubMed  Google Scholar 

  7. Bowerman RA, Samuels BI, Silver TM (1983) Ultrasonographic features of hepatic adenomas in type I glycogen storage disease. J Ultrasound Med 2:51–54

    PubMed  Google Scholar 

  8. Brunelle F, Tammam S, Odièvre M, Chaumont P (1984) Liver adenomas in glycogen storage disease in children. Ultrasound and angiographic study. Pediatr Radiol 14:94–101

    PubMed  Google Scholar 

  9. Brunn H, Schmidt E, Reinacher M, et al (1987) Histology and histochemistry of the liver of chickens after DEN-induced hepatocarcinogenesis and ingestion of low chlorinated biphenyls. Arch Toxicol 60:337–342

    PubMed  Google Scholar 

  10. Bucher NLR, Swaffield MN (1975) Regulation of hepatic regeneration by synergistic action of insulin and glucagon. Proc Nat Acad Sci USA 72:1157–1160

    PubMed  Google Scholar 

  11. Bucher NLR, Patel U, Cohen S (1978) Hormonal factors concerned with liver regeneration. In: Porter R, Whelan J (eds) Hepatotrophic factors. Elsevier, New York, pp 95–107

    Google Scholar 

  12. Bühler H, Pirovino M, Akovbiantz A, et al (1982) Regression of liver cell adenoma. A follow-up study of three consecutive patients after discontinuation of oral contraceptive use. Gastroenterology 82:775–782

    PubMed  Google Scholar 

  13. Coire CI, Qizilbash AH, Castelli MF (1987) Hepatic adenomata in type Ia glycogen storage disease. Arch Path Lab Med 111:166–169

    PubMed  Google Scholar 

  14. Couch JA, Courtney LA (1987) N-nitrosodiethylamine-induced hepatocarcinogenesis in estuarine sheephead minnow (Cyprinodon variegatus): Neoplasms and related lesions compared with mammalian lesions. J Nat Cancer Inst 79:297–321

    PubMed  Google Scholar 

  15. Denk H (1984) The intermediate filament cytoskeleton in neoplastic and non-neoplastic liver disorders. J Submicr Cytol 16:141–145

    Google Scholar 

  16. Denk H, Franke WW, Kerjaschki D, Eckerstorfer R (1979) Mallory bodies in experimental animals and man. Int Rev Exp Path 20:77–121

    PubMed  Google Scholar 

  17. Edmondson HA, Reynolds TB, Henderson B, Benton B (1977) Regression of liver cell adenomas associated with oral contraceptives. Ann Int Med 86:180–182

    PubMed  Google Scholar 

  18. Farivar JR, Wands JR, Isselbacher KJ, et al (1976) Effect of insulin and glucagon in fulminant murine hepatitis. N Engl J Med 295:1517–1519

    PubMed  Google Scholar 

  19. Fausto N (1990) Hepatic regeneration. In: Zakim D, Boyer TD (eds) Hepatology. Saunders, Philadelphia, pp 49–65

    Google Scholar 

  20. Fausto N, Mead J (1989) Regulation of liver growth: Protooncogenes and transforming growth factors. Lab Invest 60:4–13

    PubMed  Google Scholar 

  21. Fink AS, Appleman HD, Thompson NW (1985) Hemorrhage into a hepatic adenoma and type Ia glycogen storage disease: a case report and review of the literature. Surgery 97:117–123

    PubMed  Google Scholar 

  22. Fischer G, Hartmann H, Droese M, et al (1986) Histochemical and immunohistochemical detection of putative preneoplastic liver foci in woman after long-term use of oral contraceptives. Virchows Arch Path Anat B 50:321–337

    Google Scholar 

  23. Fraumeni JF, Miller RW, Hill JA (1968) Primary carcinoma of the liver in childhood: an epidemiologic study. J Nat Cancer Inst 40:1087–1099

    PubMed  Google Scholar 

  24. French SW (1983) Present understanding of the development of Mallory's body. Arch Path Lab Med 107:445–450

    PubMed  Google Scholar 

  25. Fujiyama S, Sato K, Sakai M, et al (1990) a case of type Ia glycogen storage disease complicated by hepatic adenoma. Hepato-Gastroenterology 37:432–435

    PubMed  Google Scholar 

  26. Greene HL (1982) Glycogen storage disease. Semin Liver Dis 2:291–301

    PubMed  Google Scholar 

  27. Grossman H, Ram PC, Coleman RA, et al (1981) Hepatic ultrasonography in type I glycogen storage disease (van Gierke's disease): Detection of hepatic adenomas and carcinoma. Radiology 141:753–756

    PubMed  Google Scholar 

  28. Holling HE (1963) Gout and glycogen storage disease. Ann Int Med 58:654–663

    PubMed  Google Scholar 

  29. Howell RR, Stevenson RE, Ben-Menachem J, et al (1976) Hepatic adenomata with type 1 glycogen storage disease. J Am Med Assoc 236:1481–1484

    Google Scholar 

  30. Huber BE, Dearfield KL, Williams JR, et al (1985) Tumorigenicity and transcriptional modulation of c-myc and N-ras oncogenes in a human hepatoma cell line. Cancer Res 45: 4322–4329

    PubMed  Google Scholar 

  31. Ishak KG (1979) Hepatic neoplasms associated with contraceptive and anabolic steroids. Recent Results Cancer Res 66: 73–128

    PubMed  Google Scholar 

  32. Ishak KG, Rabin L (1975) Benign tumors of the liver. Med Clin North Am 59:995–1013

    PubMed  Google Scholar 

  33. Ito E, Sato Y, Kawauchi K, et al (1987) Type Ia glycogen storage disease with hepatoblastoma in siblings. Cancer 59: 1776–1780

    PubMed  Google Scholar 

  34. Karhunen PJ, Penttilä A (1987) Preneoplastic lesions in human liver. Hepato-Gastroenterol 34:10–15

    Google Scholar 

  35. Kharsa G, Degott C, Filoche B, et al (1990) Adenome hépatique et carcinome hépatocellulaire chez deux frères atteints de glycogenose de type I. Gastroenterol Clin Biol 14:84–89

    PubMed  Google Scholar 

  36. Koch K, Leffert HL (1974) Growth control of differentiated fetal rat hepatocytes in primary monolayer culture. VI. Studies with conditioned medium and its functional interactions with serum factors. J Cell Biol 62:780–791

    PubMed  Google Scholar 

  37. Leffert HL, Koch KS, Moran T, Rubalcava B (1979) Hormonal control of rat liver regeneration. Gastroenterology 76: 1470–1482

    PubMed  Google Scholar 

  38. Leffert HL, Koch KS, Lad PJ, et al (1982) Hepatocyte growth factors. In: Zakim D, Boyer TD (eds) Hepatology, Saunders, Philadelphia, pp 64–75

    Google Scholar 

  39. Leffert HL, Koch KS, Lad PJ, et al (1983) Glucagon and liver regeneration. In: Lefebvre P (ed) Handbook of experimental pharmacology. Springer, Berlin New York Heidelberg, pp 453–484

    Google Scholar 

  40. Leffert HL, Koch KS, Lad PJ, et al (1988) Hepatocyte regeneration, replication, and differentiation. In: Arias IM, Jacoby WB, Popper H, Schachter D, Shafritz DA (eds) The liver: biology and pathobiology, Raven Press, New York, pp 833–850

    Google Scholar 

  41. Limmer J, Fleig WE, Leupold D, et al (1988) Hepatocellular carcinoma in type I glycogen storage disease. Hepatology 8:531–537

    PubMed  Google Scholar 

  42. Malatack JJ, Iwatsuki S, Gartner JC, et al (1983) Lancet I: 1073–1075

    Google Scholar 

  43. Mason HH, Andersen DH (1955) Glycogen disease of the liver (von Gierke's disease) with hepatomata: case report with metabolic studies. Pediatrics 16:785–799

    PubMed  Google Scholar 

  44. Mayer D, Klimek F, Hacker HJ, et al (1989) Carbohydrate metabolism in hepatic pre-neoplasia. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 329–345

    Google Scholar 

  45. Miller JH, Gates GF, Landing BH, et al (1978) Scintigraphic abnormalities in glycogen storage disease. J Nucl Med 19:354–358

    PubMed  Google Scholar 

  46. Moses SW (1991) Pathophysiology and dietary treatment of the glycogen storage diseases. J Pediat Gastroent Nutr (in press)

  47. Motoo Y Nahmoudi M, Osther K, Bollon AP (1986) Oncogene expression in human hepatoma cells PLC/PRF/5. Biochim Biophys Res Commun 135:262–268

    Google Scholar 

  48. Nishio S, Oka T, Tanaka K, et al (1981) Type I glycogenosis with contracted kidneys and liver cell adenoma. Acta Pathol Jpn 31:873–881

    PubMed  Google Scholar 

  49. Olàh E (1989) Pattern of oncogene expression in hepatoma cells. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 423–436

    Google Scholar 

  50. Olàh E, Natsumeda Y, Ikegami T, et al (1988) Induction of erythroid differentiation and modulation of gene expression by tiazofurin in K562 leukemia cells. Proc Nat Acad Sci USA 85:6533–6537

    PubMed  Google Scholar 

  51. Parker P, Burr I, Slonim A, et al (1981) Regression of hepatic adenomas in type Ia glycogen storage disease with dietary therapy. Gastroenterology 81:534–536

    PubMed  Google Scholar 

  52. Pizzo CJ (1980) Type I glycogen storage disease with focal nodular hyperplasia of the liver and vasoconstrictive pulmonary hypertension. Pediatrics 65:341–343

    PubMed  Google Scholar 

  53. Poe R, Snover DC (1988) Adenomas in glycogen storage disease type I. Two cases with unusual histologic features. Am J Surg Path 12:477–483

    PubMed  Google Scholar 

  54. Ruckel A, Kubale R, Marg W (1990) Leberrundherde bei Glykogenose Typ I. Leber Magen Darm 20:158–161

    PubMed  Google Scholar 

  55. Ruebner BH, Michas C, Kanayama R, Bannasch P (1976) Sequential hepatic histogenic and histochemical changes produced by diethylnitrosamine in the Rhesus monkey. J Nat Cancer Inst 57:1261–1268

    PubMed  Google Scholar 

  56. Sell S, Osborn K, Leffert HL (1981) Autoradiography of oval cells appearing rapidly in the livers of rats fed N-2-fluorenyl-acetamide in choline-devoid diet. Carcinogenesis 2:7–14

    PubMed  Google Scholar 

  57. Shimizu J, Shiraishi H, Sakurabayashi S et al (1982) A report on an adult case of type III glycogenosis with primary liver cancer and liver cirrhosis (in Japanese). Nippon Shokakibyo-Gakkai Zasshi 79:2328–2332

    PubMed  Google Scholar 

  58. Shiomi S, Saeki Y, Kim K, et al (1989) A female case of type VIII glycogenosis who developed cirrhosis of the liver and hepatocellular tumor. Gastroenterol Jpn 24:711–714

    PubMed  Google Scholar 

  59. Spycher AM, Gitzelmann R (1971) Glycogenosis type I (glucose-6-phosphatase deficiency): Ultrastructural alterations of hepatocytes in a tumor bearing liver. Virchows Arch B 8:133–142

    Google Scholar 

  60. Starzl TE, Terblanche J (1979) Hepatotrophic substances. In: Popper H, Schaffner F (eds) Prog Liver Dis vol VI; pp 135–151

  61. Starzl TE, Porter KA, Kashiwagi N, Putnam CW (1975) Portal hepatotrophic factors, diabetes mellitus, and acute liver atrophy, hypertrophy, and regeneration. Surg Gynecol Obstet 141:843–858

    PubMed  Google Scholar 

  62. Steinbrecher UB, Lisbona R, Huang SN, Mishkin S (1981) Complete regression of hepatocellular adenoma after with-drawal of oral contraceptives. Dig Dis Sci 26:1045–1050

    PubMed  Google Scholar 

  63. Stenbäck F, Mori H, Furuya K, Williams GM (1986) Pathogenesis of dimethylnitrosamine-induced hepatocellular cancer in hamster liver and lack of enhancement by phenobarbital. J Nat Cancer Inst 76:327–333

    PubMed  Google Scholar 

  64. Tricot GJ, Jayaram HN, Nichols CR, et al (1987) Hematological and biochemical action of tiazofurin in a case of refractory acute myeloid leukemia. Cancer Res 47:4988–4991

    PubMed  Google Scholar 

  65. Vesselinovitch SD, Hacker HJ, Bannasch P (1985) Histochemical characterization of focal hepatic lesions induced by single diethylnitrosamine treatment in infant mice. Cancer Res 45: 2774–2780

    PubMed  Google Scholar 

  66. Weber G (1968) Carbohydrate metabolism in cancer cells and the molecular correlation concept. Naturwissenschaften 55: 418–429

    PubMed  Google Scholar 

  67. Weber G (1977) Enzymology of cancer cells N Engl J Med 296:486–493; 541–551

    PubMed  Google Scholar 

  68. Weber G (1983) Biochemical strategy of cancer cells and the design of chemotherapy. Cancer Res 43:3466–3492

    PubMed  Google Scholar 

  69. Weber G (1989) Biochemical strategy of hepatocellular carcinoma. In: Bannasch P, Keppler D, Weber G (eds) Liver cell carcinoma. Kluwer, Dordrecht, pp 361–374

    Google Scholar 

  70. Weber G, Jayaram HN, Lapis E, et al (1988) Enzyme-pattern-targeted chemotherapy with tiazofurin and allopurinol in human leukemia. Adv Enzyme Regul 27:405–433

    PubMed  Google Scholar 

  71. Zangeneh F, Limbeck GA, Brown BI, et al (1969) Hepatorenal glycogenosis (type I glycogenosis) and carcinoma of the liver. J Pediatr 74:73–83

    PubMed  Google Scholar 

  72. Zhang XK, Huang DP, Chiu DK, Chiu JF (1987) The expression of oncogenes in human developing liver and hepatomas. Biochim Biophys Res Comm 142:932–938

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pathology, University of Basel, Schönbeinstrasse 40, CH-4003, Basel, Switzerland

    L. Bianchi

Authors
  1. L. Bianchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bianchi, L. Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr 152 (Suppl 1), 63–70 (1993). https://doi.org/10.1007/BF02072092

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02072092

Key words

Search

Navigation